Compare DMRA & CRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DMRA | CRI |
|---|---|---|
| Founded | 2011 | 1865 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Apparel |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.5B |
| IPO Year | 2020 | 2002 |
| Metric | DMRA | CRI |
|---|---|---|
| Price | $31.80 | $37.56 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 2 | 6 |
| Target Price | ★ $43.00 | $35.60 |
| AVG Volume (30 Days) | 372.2K | ★ 1.0M |
| Earning Date | 05-11-2026 | 05-12-2026 |
| Dividend Yield | N/A | ★ 2.74% |
| EPS Growth | ★ 121.48 | N/A |
| EPS | N/A | ★ 3.26 |
| Revenue | N/A | ★ $2,898,426,000.00 |
| Revenue This Year | N/A | $4.57 |
| Revenue Next Year | N/A | $1.12 |
| P/E Ratio | ★ N/A | $11.60 |
| Revenue Growth | N/A | ★ 1.91 |
| 52 Week Low | $16.50 | $24.71 |
| 52 Week High | $34.89 | $44.44 |
| Indicator | DMRA | CRI |
|---|---|---|
| Relative Strength Index (RSI) | 60.76 | 41.27 |
| Support Level | $22.71 | $37.18 |
| Resistance Level | $31.77 | $39.16 |
| Average True Range (ATR) | 1.63 | 1.51 |
| MACD | 0.02 | -0.16 |
| Stochastic Oscillator | 87.75 | 39.18 |
Damora Therapeutics Inc is a biotechnology company that aims to fundamentally redefine care for people with hematologic disorders. The group is advancing a new generation of biologics to treat mutant calreticulin-driven myeloproliferative neoplasms, including essential thrombocythemia and myelofibrosis, where there is cruicial medical need for disease-modifying treatments. Its goal is to rapidly bring forward optimized therapies with broad mutation coverage and exceptional convenience to dramatically improve patient outcomes. The group's pipeline products are DMR-001, DMR-002, DMR-003, and GB3226.
Carter's Inc makes apparel for babies and children under brand names including Carter's and OshKosh B'gosh. It sells its products through a multi-channel business model, which includes retail stores, eCommerce, and wholesale sales channels, as well as retail omnichannel capabilities in the United States and Canada, which enables it to reach a broad range of consumers around the world. The company operates in three segments; U.S. Retail, U.S. Wholesale, and International. The majority of revenue is derived from U.S. Wholesale segment. The company predominantly sources products through contract manufacturers in Asia. It has multiple distribution centers in the U.S., in addition to distribution centers in Canada and Asia that serve international customers.